5.000USD+1.63%Mkt Cap: 6.34M USDP/E: 0.00Last update: 2026-06-01
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap6.34M USD
Enterprise Value-3.98M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-25.97M USD
Revenue/Share—
Last Price5.000 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees33
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS03835L2079
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.23
PEG—
EV/EBITDA0.15
EV/Revenue—
P/S—
P/B0.51
EPS (TTM)1488.13
EPS (Forward)-21.46
52W Range
3.8001% of range235.98
52W High235.98 USD
52W Low3.800 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-149.40%
ROA-95.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.59M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-281.81%
Net Debt-10.10M USD
Net Debt/EBITDA0.38
Balance Sheet
Debt/Equity0.27
Current Ratio3.36
Quick Ratio3.05
Book Value/Sh9.646 USD
Cash/Share11.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 27, 2020
Splits
Last Split1:18
Split DateDec 30, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)21.00 USD
Target Range21.00 USD – 21.00 USD
# Analysts1
Ownership
Shares Out.1.25M
Float1.25M
Insiders0.06%
Institutions4.47%
Short Interest
Short Ratio2.2d
Short % Float7.05%
Short % Out.7.05%
Shares Short87.84K
Short (prev mo.)104.24K
Technical
SMA 504.746 (+5.4%)
SMA 20016.08 (-68.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)36.04K
Avg Vol (10d)29.47K
Technical Indicators
RSI (14)51.0
MACD-0.0255
MACD Signal-0.0489
MACD Hist.+0.0235
BB Upper5.343 USD
BB Middle4.881 USD
BB Lower4.418 USD
BB Width18.95%
ATR (14)0.3378 USD
Vol Ratio (20d)0.42x